Arizona Cancer Center Biospecimen Repository

March 30, 2026 updated by: University of Arizona

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Study Overview

Status

Recruiting

Conditions

Cancer

Intervention / Treatment

Other: biologic sample preservation procedure

Detailed Description

OBJECTIVES:

Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer.
Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine.
Provide quality-controlled storage and management of the specimen bank.
Collect relevant clinical and pathologic information with appropriate privacy protection.
Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

Study Type

Observational

Enrollment (Estimated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Arizona Cancer Center at University of Arizona Health Sciences
Phone Number: 520-626-0950

Study Locations

United States
- Arizona
  - Tucson, Arizona, United States, 85724-5024
    - Recruiting
    - Arizona Cancer Center at University of Arizona Health Sciences Center
    - Contact:
      
      Setsuko K. Chambers, MD
      
      Phone Number: 866-278-1554

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

The goal of this protocol is to provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer by collecting and preserving tissue from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing. No additional tissue will be taken at the time of surgery other than that required for patient care, but additional blood and urine samples will be obtained at that time. This protocol is not limited to certain types of cancer.

Description

DISEASE CHARACTERISTICS:

Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

PRIOR CONCURRENT THERAPY:

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Provision of tissue samples and biospecimens for translational study Time Frame: July 2024	An electronic record of the specimens is kept in a secure, web-based database. Follow-up information will be obtained from the patient medical record or from the patient.	July 2024

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Arizona

Collaborators

National Cancer Institute (NCI)

Investigators

Principal Investigator: Setsuko K. Chambers, MD, University of Arizona

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Clinical trial summary from the National Cancer Institute's PDQ® database

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2006

Primary Completion (Estimated)

July 1, 2030

Study Completion (Estimated)

July 1, 2030

Study Registration Dates

First Submitted

May 9, 2009

First Submitted That Met QC Criteria